Press Release - | CBD Nutraceuticals Market to Reach Valuation of USD 28.2 Billion by 2030 – Growing Acceptance of Cannabis and CBD as a Legitimate Treatment Option Drives the Market |
Vantage Market Research | 01 Aug 2023
Biotechnology and Life Sciences
CBD Nutraceuticals Market to Reach Valuation of USD 28.2 Billion by 2030 – Growing Acceptance of Cannabis and CBD as a Legitimate Treatment Option Drives the Market
In terms of revenue, the Global CBD Nutraceuticals Market Market is expected to reach USD 28.2 Billion by 2030, growing at a CAGR (Compound Annual Growth Rate) of 18.9% from 2023 to 2030.
The CBD Nutraceuticals Market refers to using CBD supplements in various forms, including capsules, tinctures, and gummies. Nutraceuticals are derived from natural sources, including herbal plants, fruits, and vegetables, and are known to impact the human body positively. CBD is an effective Nutraceutical used to treat different ailments due to its anti-inflammatory, anti-anxiety, and analgesic properties. The increasing demand for Cannabis-based products for therapeutic purposes, increased knowledge of CBD health advantages, and the legalization of Cannabis in numerous countries worldwide are driving market expansion.
Key Highlights from the Report
Market Dynamics
The market for CBD Nutraceuticals Market is rapidly expanding, with many companies now offering CBD-infused products such as edibles, tinctures, and topicals. CBD is a non-psychoactive chemical present in the cannabis plant that is thought to provide a variety of therapeutic advantages, such as pain alleviation, anxiety reduction, and enhanced sleep. Several factors, including the growing acceptance of Cannabis and CBD as a legitimate treatment option by consumers and healthcare professionals, drive the CBD Nutraceuticals Market. There is also a growing awareness of the potential health benefits of these products, as well as improved education and research into the possible uses of CBD.
Another key driving force behind the CBD Nutraceuticals Market is the changing legal landscape surrounding Cannabis and CBD. In the United States, the legalization of Cannabis at the state level has led to a patchwork of regulations that vary from state to state, with some allowing for the use of Cannabis and CBD for medical purposes. In addition, the passage of the 2018 Farm Bill in the United States effectively legalized hemp and CBD products nationwide, leading to a surge in demand for these products.
The CBD (cannabidiol) nutraceuticals market in North America has been experiencing significant growth in 2021. Several factors have contributed to this growth, including the increased acceptance and legalization of cannabis in various states in the United States and Canada. The growing acceptance of CBD among healthcare professionals is also boosting market growth. Many doctors and healthcare practitioners recommend CBD products as part of their treatment plans for certain conditions. This endorsement has significantly influenced public perception, increasing adoption of CBD Nutraceuticals Market. Additionally, the ease of access to CBD products has played a crucial role in market growth. CBD Nutraceuticals Market are available in various forms, including oils, tinctures, capsules, topicals, and edibles, easily purchased from dispensaries, online stores, and wellness shops. The convenience and availability of these products have attracted a broader customer base.
The Global CBD Nutraceuticals Market is Segmented as follows
List of the Key Players of the Global CBD Nutraceuticals Market is
[object Object]
The Global CBD Nutraceuticals Market Scope can be Tabulated as below
Parameter | Details |
---|---|
Market Size Provided for Years | 2016-2028 |
Base Year | 2021 |
Historic Years | 2016-2020 |
Forecast Years | 2022-2028 |
Segments Covered |
|
Region & Counties Covered |
|
Companies Covered |
|
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis |
About Vantage Market Research:
We, at Vantage Market Research, provide quantified B2B high quality research on more than 20,000 emerging markets, in turn, helping our clients map out constellation of opportunities for their businesses. We, as a competitive intelligence market research and consulting firm provide end to end solutions to our client enterprises to meet their crucial business objectives. Our clientele base spans across 70% of Global Fortune 500 companies. The company provides high quality data and market research services. The company serves various enterprises and clients in a wide variety of industries. The company offers detailed reports on multiple industries including Chemical Materials and Energy, Food and Beverages, Healthcare Technology, etc. The company’s experienced team of Analysts, Researchers, and Consultants use proprietary data sources and numerous statistical tools and techniques to gather and analyse information.
Biotechnology and Life Sciences
CBD Nutraceuticals Market to Reach Valuation of USD 28.2 Billion by 2030 – Growing Acceptance of Cannabis and CBD as a Legitimate Treatment Option Drives the Market
01 Aug 2023
Min Read
Access Full Report
CBD Nutraceuticals Market to Reach Valuation of USD 28.2 Billion by 2030 – Growing Acceptance of Cannabis and CBD as a Legitimate Treatment Option Drives the Market
This report by Vantage Market Research delivers comprehensive analysis of Somatostatin Analogs Market , focusing on Market Size, Share & Trends Analysis Report by Type (Octreotide, Lanreotide, Pasireotide) by Application (Acromegaly, Neuroendocrine Tumors (NETs), Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Request SampleRelated Reports
Contact
Toll Free Number+1 (877) 462-2282